Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avidity Biosciences (RNA) Prepaid Assets: 2019-2024

Historic Prepaid Assets for Avidity Biosciences (RNA) over the last 6 years, with Dec 2024 value amounting to $40.8 million.

  • Avidity Biosciences' Prepaid Assets rose 171.03% to $90.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $90.2 million, marking a year-over-year increase of 171.03%. This contributed to the annual value of $40.8 million for FY2024, which is 155.66% up from last year.
  • Latest data reveals that Avidity Biosciences reported Prepaid Assets of $40.8 million as of FY2024, which was up 155.66% from $16.0 million recorded in FY2023.
  • Avidity Biosciences' Prepaid Assets' 5-year high stood at $40.8 million during FY2024, with a 5-year trough of $3.5 million in FY2020.
  • In the last 3 years, Avidity Biosciences' Prepaid Assets had a median value of $16.0 million in 2023 and averaged $23.0 million.
  • Data for Avidity Biosciences' Prepaid Assets shows a peak YoY skyrocketed of 222.13% (in 2020) over the last 5 years.
  • Avidity Biosciences' Prepaid Assets (Yearly) stood at $3.5 million in 2020, then soared by 58.27% to $5.6 million in 2021, then skyrocketed by 118.20% to $12.2 million in 2022, then surged by 30.63% to $16.0 million in 2023, then spiked by 155.66% to $40.8 million in 2024.